Cargando…

The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis

BACKGROUND: Current WHO guidelines (2018) recommend screening for cryptococcal antigen (CrAg) in HIV-infected persons with CD4+ T cell counts< 100 cells/μL, followed by pre-emptive antifungal therapy among CrAg positive (CrAg+) persons, to prevent cryptococcal meningitis related deaths. This stra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yao, Huang, Xiaojie, Chen, Hui, Qin, Yuanyuan, Hou, Jianhua, Li, Aixin, Wu, Hao, Yan, Xiaofeng, Chen, Yaokai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291520/ https://www.ncbi.nlm.nih.gov/pubmed/32532212 http://dx.doi.org/10.1186/s12879-020-05126-z

Ejemplares similares

Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
por: Li, Yao, et al.
Publicado: (2021)

Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014–2015
por: Haumba, Samson M., et al.
Publicado: (2020)

Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023)

1497. Cryptococcal Antigen Screening and Pre-emptive Fluconazole Therapy in HIV-infected Patients: A Multicenter, Retrospective Study in China
por: Lu, Yanqiu, et al.
Publicado: (2023)

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
por: Ramachandran, Anu, et al.
Publicado: (2017)

Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa
por: Cassim, Naseem, et al.
Publicado: (2017)

Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2021)

Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment
por: Sawadogo, Souleymane, et al.
Publicado: (2016)

Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients
por: Kwizera, Richard, et al.
Publicado: (2017)

Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil
por: Borges, Moara Alves Santa Bárbara, et al.
Publicado: (2019)

Crag Martin neontology complements taphonomy at the Gorham's Cave Complex
por: Bensusan, Keith, et al.
Publicado: (2021)

What Is the Most Appropriate Induction Regimen for the Treatment of HIV-Associated Cryptococcal Meningitis When the Recommended Regimen Is Not Available? Evidence From a Network Meta-Analysis
por: Li, Yao, et al.
Publicado: (2020)

Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2021)

Climbing crags recommender system in Arco, Italy: a comparative study
por: Ivanova, Iustina, et al.
Publicado: (2023)

Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis
por: Qin, Yuanyuan, et al.
Publicado: (2020)

Crag Is a GEF for Rab11 Required for Rhodopsin Trafficking and Maintenance of Adult Photoreceptor Cells
por: Xiong, Bo, et al.
Publicado: (2012)

1485. Landscape of peripheral blood mononuclear cell single-cell transcriptomes in HIV-infected patients with cryptococcal meningitis
por: Chen, Yaokai, et al.
Publicado: (2023)

CRAG: de novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing
por: Zhou, Xionghui, et al.
Publicado: (2022)

Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis
por: Mimicos, Evanthia Vetos, et al.
Publicado: (2022)

Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
por: Awotiwon, Ajibola A, et al.
Publicado: (2018)

Differential Antifungal Activity of Human and Cryptococcal Melanins with Structural Discrepancies
por: Correa, Néstor, et al.
Publicado: (2017)

Forebrain-specific deficiency of the GTPase CRAG/Centaurin-γ3 leads to immature dentate gyri and hyperactivity in mice
por: Nagashima, Shun, et al.
Publicado: (2021)

Concrol desk in Μ.C.R
por: Brianti, G, et al.
Publicado: (1960)

Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review
por: Costiniuk, Cecilia T., et al.
Publicado: (2011)

Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease
por: Coetzee, Lindi-Marie, et al.
Publicado: (2018)

A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis
por: Li, Aixin, et al.
Publicado: (2021)

A novel GTPase, CRAG, mediates promyelocytic leukemia protein–associated nuclear body formation and degradation of expanded polyglutamine protein
por: Qin, Qingyu, et al.
Publicado: (2006)

Potential Predictors and Survival Analysis of the Relapse of HIV-Associated Cryptococcal Meningitis: A Retrospective Study
por: Li, Yao, et al.
Publicado: (2021)

Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents
por: Huang, Liang, et al.
Publicado: (2015)

Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis
por: O’Connor, Lucy, et al.
Publicado: (2020)

Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania
por: Kisenge, Peter R, et al.
Publicado: (2007)

Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality
por: Musubire, Abdu Kisekka, et al.
Publicado: (2018)

Pd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal Effect
por: Zhang, Chao, et al.
Publicado: (2016)

Efficacy and Safety of Oral TDF-Based Pre-exposure Prophylaxis for Men Who Have Sex With Men: A Systematic Review and Meta-Analysis
por: Huang, Xiaojie, et al.
Publicado: (2018)

Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia
por: Fung, Monica, et al.
Publicado: (2015)

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm(3)
por: Wykowski, James, et al.
Publicado: (2020)

Regional blocks for pre-emptive anti-emesis
por: Gupta, Deepak
Publicado: (2012)

Pre-emptive genomic surveillance of emerging ebolaviruses
por: Postigo-Hidalgo, Ignacio, et al.
Publicado: (2020)

Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
por: Chatterjee, Kaushik, et al.
Publicado: (2022)

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART
por: Lapadula, Giuseppe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_313lro8d6mnv1h0hn1hbf577pf